About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT05529914

Effects of Myofascial Release and Neuromuscular Training for Pes Anserine Syndrome Associated With Knee Osteoarthritis

A randomized control trial will be conducted at the outpatient department of Dow Institute of Physical Medicine and Rehabilitation. A sample size of 80 is calculated using PASS version 11 software. Th...

Lead sponsor: Dow University of Health Sciences•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

Dow University of Health Sciences

Age

40 - 60 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Male and Females both with the age between 40-60 years.
•Patients with unilateral or bilateral knee osteoarthritis with pes anserine syndrome.
•Patients with knee pain more than 3.4 cm on visual analogue scale as minimum cut of value.
•Kellgren and Lawrence grade II and III on radiological findings.
•Duration of knee osteoarthritis more than 3 months (chronic).

Exclusion Criteria

•Patients with any neurological disorder.
•Knee deformities such as contractures, genu valgum and genu varum.
•Septic knee arthritis.
•History of ligamentous injury or meniscal tear.
•Cancer or any other malignancy or bone tumor.
•Any history of previous lower limb arthroplasty or other knee surgery.
•Comorbid like diabetes mellitus.
•Inflammatory rheumatic disease (R.A).

Related studies

Comparative Efficacy of Intra-articular vs. MRI-guided Extra-articular Dextrose Injections in Knee Osteoarthritis Management

NCT06755697 · Knee Osteoarthritis, Glucose, and more

RECRUITINGPhase 2

A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis

NCT07225829 · Knee Osteoarthritis, Synovitis of Knee

RECRUITINGPhase 1

A Phase Ib Study to Evaluate the Efficacy and Safety of HRS-2129 in Patients With Knee Osteoarthritis

NCT07351968 · Moderate Pain in Knee Osteoarthritis, Severe Pain in Knee Osteoarthritis

General vs Spinal in Total Joint Arthroplasty (TJA)

NCT06747494 · Knee Osteoarthritis, Hip Osteoarthritis

RECRUITINGPhase 1/2

Recombinant Human Growth Hormone (rHGH) for Knee Osteoarthritis (KORR)

NCT07036003 · Knee Osteoarthritis (Knee OA), Knee Osteoarthritis (OA)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 9, 2024Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment80

Start dateSep 2022

Last updatedJan 9, 2024

Condition

Knee Osteoarthritis Pes Anserine Bursitis

Locations shown

Dow Institute of Physical Medicine and Rehabilitation

Karachi, Sindh

Sindh Institute of Physical Medicine and Rehabilitation

Karachi, Sindh

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 9, 2024Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions